GNPX Genprex Inc.

0.9
-0.02  -2%
Previous Close 0.92
Open 0.92
Price To Book 2.65
Market Cap 14,258,570
Shares 15,842,855
Volume 12,945
Short Ratio
Av. Daily Volume 56,448

NewsSee all news

  1. Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019

    Genprex, Inc. (NASDAQ:

  2. Independent Researchers Find Genprex's TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer

    A direct target of miR-138, TUSC2 mimics miR-138 knockdown

  3. Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments

    NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled "Gene Therapy Treatments Offer Hope for Cancer

  4. Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer

    NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and

  5. Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference

    Genprex, Inc. (NASDAQ:

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 interim data released January 2017. Patient enrollment to resume - noted August 2, 2018.
Oncoprex With Tarceva
Non-small cell lung cancer (NSCLC)

Latest News

  1. Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019

    Genprex, Inc. (NASDAQ:

  2. Independent Researchers Find Genprex's TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer

    A direct target of miR-138, TUSC2 mimics miR-138 knockdown

  3. Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments

    NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled "Gene Therapy Treatments Offer Hope for Cancer

  4. Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer

    NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and

  5. Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference

    Genprex, Inc. (NASDAQ:

  6. Genprex Provides Forward Looking Guidance and Updates on Corporate Activities, Publishes New Corporate Deck

    Genprex, Inc. (NASDAQ:

  7. Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector

    NEW YORK, Aug. 23, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of an audio press release broadcast titled, "Record Revenues, Milestone Achievements Indicate

  8. Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company's Milestone Achievements

    NEW YORK, Aug. 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and